Wed, Sep 21, 2022
The commercial launch of a new vaccine 'Lumpi-ProVacInd' for LSD, developed by two institutes of agri research body ICAR, will take the next "three-four months.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.